tiprankstipranks
AbbVie (ABBV)
NYSE:ABBV

AbbVie (ABBV) Technical Analysis

20,148 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is -1.65, suggesting AbbVie is a Sell.
AbbVie’s (ABBV) 20-Day exponential moving average is 163.53, while AbbVie’s (ABBV) share price is $164.35, making it a Buy.
AbbVie’s (ABBV) 50-Day exponential moving average is 166.17, while AbbVie’s (ABBV) share price is $164.35, making it a Sell.

AbbVie (ABBV) Pivot Points

May 17, 2024, 03:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
159.75
160.81
162.30
163.36
164.85
165.91
167.40
Fibonacci
160.81
161.78
162.39
163.36
164.33
164.94
165.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

May 17, 2024, 03:49 PM
Period
Simple
Exponential
MA5
162.35Buy
162.89Buy
MA10
162.17Buy
162.58Buy
MA20
163.35Buy
163.53Buy
MA50
169.28Sell
166.17Sell
MA100
167.84Sell
164.26Buy
MA200
155.78Buy
155.31Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 162.58, while AbbVie’s (ABBV) share price is $164.35, making it a Buy.
AbbVie’s (ABBV) 100-Day exponential moving average is 164.26, while AbbVie’s (ABBV) share price is $164.35, making it a Buy.
AbbVie’s (ABBV) stock price is $164.35 and AbbVie’s (ABBV) 50-day simple moving average is 169.28, creating a Sell signal.
AbbVie’s (ABBV) stock price is $164.35 and AbbVie’s (ABBV) 100-day simple moving average is 167.84, creating a Sell signal.
AbbVie’s (ABBV) stock price is $164.35 and AbbVie’s (ABBV) 200-day simple moving average is 155.78, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

May 17, 2024, 03:49 PM
Name
Value
Implied Action
RSI (14)
49.71
Neutral
STOCH (9,6)
75.00
Neutral
STOCHRSI (14)
62.64
Neutral
MACD (12,26)
-1.65
Sell
ADX (14)
30.27
Neutral
Williams %R
-8.52
Sell
CCI (14)
15.95
Neutral
ATR (14)
3.04
-
Ultimate Oscillator
53.86
Neutral
ROC
2.96
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 49.71, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 30.27, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is 15.95, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 2.96, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Buy.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 49.71, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is -1.65, which suggests ABBV is a Sell.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 162.35, which suggests ABBV is a Buy.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 163.35, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 169.28, which suggests ABBV is a Sell.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 155.78, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -8.52, which suggests ABBV is a Sell.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is 15.95, which suggests ABBV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis